Join the club for FREE to access the whole archive and other member benefits.

Sarcopenia News

Sarcopenia is linked to ageing hallmarks, causing muscle decline

Live Forever Club - 08-Dec-2024

Mitochondrial dysfunction is most strongly linked to muscle decline

Read more...

Muscle matters: building strength for healthy ageing

The Conversation (UK) - 27-Nov-2024

How exercise and nutrition can help you stay active, independent, and well as you grow older

Read more...

Rejuvenate Biomed's potential drug candidate combats sarcopenia in older adults

Rejuvenate Biomed - 21-Feb-2024

Phase 1b trial shows RJx-01's ability to improve muscle strength, function, and fatigue resistance

Read more...

Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging

Business Wire - 26-Jul-2022

Sarcopenia drug trial shows no evidence of toxicity or safety issues

Read more...

Sarconeos BIO101 in development for the treatment of Sarcopenia by Biophytis

Yahoo! finance - 27-Jun-2022

SARA-INT Phase 2 study and SARA Phase 3 study milestones in developing sarconeos

Read more...

MyMD Pharmaceuticals begins phase 2 trial of TNF-inhibitor in January 2022

Longevity Technology - 14-Dec-2021

Potential oral treatment to prevent sarcopenia and frailty, and extend healthy lifespan

Read more...

Role of Neuromuscular junction in ageing and neuro muscular diseases

Fight Aging! - 17-Aug-2021

Neuromuscular junction: A potential therapeutic target in neuromuscular injury

Read more...

Klotho protein reversed muscle ageing in old, but not older mice

eLife Sciences - 20-Apr-2021

Potential future treatment strategy to prevent sarcopenia when supplemented at a young age

Read more...

A man-made molecule that helps repair and regenerate muscle tissue

EurekAlert! - 23-Mar-2021

Givinostat induces stem cells to produce muscle making cells - promising therapy for age-related muscle loss

Read more...

Rejuvenate Biomed raises 3.2 million euros for anti-ageing drugs

PharmiWeb.com - 02-Mar-2021

Accelerates clinical trial plans for its lead candidate Rlx-01 targeting age-related muscle failure

Read more...